• 1
    Caulkins J. P., Reuter P., Coulson C. Basing drug scheduling decisions on scientific ranking of harmfulness: false promise from false premises. Addiction 2011; Epub ahead of print. doi:10.1111/j.1360-0443.2011.03461.x.
  • 2
    Nutt D., King L., Saulsbury C., Blakemore C. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet 2007; 369: 104753.
  • 3
    Nutt D. J., King L. A., Phillips L. D. Drug harms in the UK: a multicriteria decision analysis. Lancet 2010; 376: 155865.
  • 4
    Hall W., Room R., Bondy S. Comparing the health and psychological risks of alcohol, cannabis, nicotine and opiate use. In: Kalant H., Corrigal W., Hall W., Smart R., editors. The Health Effects of Cannabis. Toronto: Addiction Research Foundation; 1999, p. 476506.
  • 5
    Roques B. La dangerosité des drogues, rapport au Secrétariat d'Etat à la Santé[The dangerousness of drugs: report to the State Secretariat for Health]. Paris: La Documentation française—Odile Jacob; 1999.
  • 6
    Fischer B., Kendall P., Rehm J., Room R. Charting WHO—goals for licit and illicit drugs for the year 2000: are we ‘on track’? Public Health 1997; 111: 21775.
  • 7
    Babor T., Caulkins J. P., Griffith E., Fischer B., Foxcroft D. R., Humphreys K. et al. Drug Policy and the Public Good. Oxford: Oxford University Press; 2010.
  • 8
    Desjardins N., Hotton T. Trends in drug offences and the role of alcohol and drugs in crime. Juristat (Statistics Canada, Catalogue 85-002); 2004; 24: 124.
  • 9
    Fischer B. Prohibition, public health and a window of opportunity: an analysis of Canadian drug policy, 1985–1997. Policy Stud 1999; 20: 197210.
  • 10
    Room R., Fischer B., Hall W., Lenton S., Reuter P. Cannabis Policy: Moving beyond Stalemate. New York: Oxford University Press; 2010.
  • 11
    Fischer B., Rehm J., Irving H., Ialomiteanu A., Fallu J.-S., Patra J. Typologies of cannabis users and associated characteristics relevant for public health: a latent class analysis of data from a nationally representative Canadian adult survey. Int J Methods Psychiatr Res 2010; 19: 11024.
  • 12
    Giffen J., Endicott S., Lambert S. Panic and Indifference—The Politics of Canada's Drug Laws. Ottawa: Canadian Centre on Substance Abuse; 1991.
  • 13
    Green M. A history of Canadian narcotics control: ‘the formative years’. Univ Tor Fac Law Rev 1979; 37: 4279. Tobacco Control: Comparative Politics in the United States and Canada.
  • 14
    Studlar D. Tobacco Control: Comparative Politics in the United States and Canada. Toronto: Broadview Press; 2002.
  • 15
    Cunningham R. Smoke and Mirrors: the Canadian Tobacco War. Ottawa: International Development Research Centre; 1996.
  • 16
    Heron C. Booze: A Distilled History. Toronto: Between the Lines; 2003.
  • 17
    Kerr T., Small D., Wood E. The public health and social impacts of drug market enforcement: A review of the evidence. Int J Drug Policy 2005; 16: 21020.
  • 18
    Rhodes T., Singer M., Bourgois P., Friedman S., Strathdee S. The social structural production of HIV risk among injecting drug users. Soc Sci Med 2005; 61: 102644.
  • 19
    Wood E., Tyndall M., Spittal P., Li K., Anis A. H., Hogg R. et al. Impact of supply-side policies for control of illicit drugs in the face of the AIDS and overdose epidemics: investigation of a massive heroin seizure. Can Med Assoc J 2003; 168: 1659.